CTX-471
CTX-471-001
Phase 1 small_molecule completed
Quick answer
CTX-471 for Locally Advanced Solid Tumor is a Phase 1 program (small_molecule) at Compass Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Compass Therapeutics
- Indication
- Locally Advanced Solid Tumor
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed